Baseline Clinical and Neuroimaging Biomarkers of Treatment Response to High-Frequency rTMS Over the Left DLPFC for Resistant Depression

Baseline Clinical and Neuroimaging Biomarkers of Treatment Response to High-Frequency rTMS Over the Left DLPFC for Resistant Depression

BackgroundRepetitive transcranial magnetic stimulation (rTMS) has proven to be an efficient treatment option for patients with treatment-resistant depression (TRD). However, the success rate of this method is still low, and the treatment outcome is unpredictable. The objective of this study was to e...

Full description

Bibliographic Details
Main Authors: Ghina Harika-Germaneau, Issa Wassouf, Tom Le Tutour, Remy Guillevin, Damien Doolub, Reza Rostami, Alexia Delbreil, Nicolas Langbour, Nematollah Jaafari
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Psychiatry
Subjects:
rTMS (repetitive transcranial magnetic stimulation)
major depression (MDD)
bipolar disorder
structural MRI (sMRI)
DLPFC (dorsolateral prefrontal cortex)
high-frequency
Online Access:https://www.frontiersin.org/articles/10.3389/fpsyt.2022.894473/full

Internet

https://www.frontiersin.org/articles/10.3389/fpsyt.2022.894473/full

Similar Items